Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Lucira Health's share price for the quarter that ended in Sep. 2022 was $1.06. Lucira Health's Shares Outstanding (EOP) for the quarter that ended in Sep. 2022 was 40.4 Mil. Therefore, Lucira Health's market cap for the quarter that ended in Sep. 2022 was $42.9 Mil.
Lucira Health's quarterly market cap
declined
from Mar. 2022 ($142.3 Mil) to Jun. 2022 ($74.6 Mil) and
declined
from Jun. 2022 ($74.6 Mil) to Sep. 2022 ($42.9 Mil).
Lucira Health's annual market cap
stayed the same
from Dec. 2019 ($0.0 Mil) to Dec. 2020 ($0.0 Mil) but then
increased
from Dec. 2020 ($0.0 Mil) to Dec. 2021 ($341.5 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Lucira Health's Enterprise Value for Today is $8.3 Mil.
Lucira Health Market Cap Historical Data
The historical data trend for Lucira Health's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Lucira Health's Market Cap
For the Medical Devices subindustry, Lucira Health's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lucira Health's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lucira Health's Market Cap distribution charts can be found below:
* The bar in red indicates where Lucira Health's Market Cap falls into.
Lucira Health Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Lucira Health's Market Cap for the fiscal year that ended in Dec. 2021 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lucira Health (OTCPK:LHDXQ) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Lucira Health Market Cap Related Terms
Thank you for viewing the detailed overview of Lucira Health's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Lucira Health (Lucira Health) Business Description
Lucira Health Inc is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. It has developed a testing platform that produces high-complexity-laboratory-accurate molecular testing in a single-use and user-friendly test kit that is powered by two AA batteries and fit in the palm of a hand. The company's initial focus is within respiratory diseases, and initially for COVID-19 and influenza Types A and B indications.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LHDXQ has been successfully added to your 